Toggle Main Menu Toggle Search

Open Access padlockePrints

Dystrophin isoform deficiency and upper-limb and respiratory function in Duchenne muscular dystrophy

Lookup NU author(s): Professor Volker StraubORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025 The Author(s). Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press. Aim: To investigate the associations between mutations expected to differentially affect Dp140 expression and long-term trajectories of respiratory and upper-limb motor outcomes in Duchenne muscular dystrophy (DMD). Method: In a retrospective analysis of population-based longitudinal data from three real-world and natural history data sources, individuals with DMD aged 5 years to 18 years were subdivided according to the predicted effects of the participants' DMD mutation on dystrophin isoform expression (group 1, Dp427 absent, Dp140/Dp71 present; group 2, Dp427/Dp140 absent, Dp71 present). Results: A total of 459 participants were studied, with upper-limb outcomes assessed in 71 (27 in group 1 and 44 in group 2) and forced vital capacity percentage predicted (%pred) assessed in 434 (224 in group 1 and 210 in group 2). Mean grip strength %pred was on average 7.1 percentage points lower in group 2 than in group 1 (p = 0.03). Mean pinch strength %pred was on average 9.2 percentage points lower in group 2 than in group 1 (p = 0.04). Mean forced vital capacity %pred was on average 4.3 percentage points lower in group 2 than in group 1 (p = 0.01). Interpretation: In individuals with DMD, DMD mutations predicted to affect Dp140 expression were associated with more severe trajectories of respiratory and upper-limb motor outcomes.


Publication metadata

Author(s): Chesshyre M, Ridout D, Stimpson G, Ricotti V, De Lucia S, Niks EH, Straub V, Servais L, Hogrel J-Y, Baranello G, Manzur A, UK NorthStar Clinical Network, Muntoni F, on behalf of the iMDEX Network

Publication type: Article

Publication status: Published

Journal: Developmental Medicine and Child Neurology

Year: 2025

Pages: Epub ahead of print

Online publication date: 14/03/2025

Acceptance date: 24/01/2025

Date deposited: 10/04/2025

ISSN (print): 0012-1622

ISSN (electronic): 1469-8749

Publisher: John Wiley and Sons Inc.

URL: https://doi.org/10.1111/dmcn.16282

DOI: 10.1111/dmcn.16282

Data Access Statement: The data that support the findings of this study are available from the corresponding author (Francesco Muntoni) upon reasonable request.

PubMed id: 40084496


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
ADNA (Advanced Diagnostics for New Therapeutic Approaches) supported by the French public agency, OSEO
L'Association Française contre les Myopathies
Muscular Dystrophy UK. Grant Number: 22GRO-PG24-0598

Share